BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14996114)

  • 1. Recalcitrant, generalized pustular psoriasis: rapid and lasting therapeutic response to antitumour necrosis factor-alpha antibody (infliximab).
    Schmick K; Grabbe J
    Br J Dermatol; 2004 Feb; 150(2):367. PubMed ID: 14996114
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease).
    Voigtländer C; Lüftl M; Schuler G; Hertl M
    Arch Dermatol; 2001 Dec; 137(12):1571-4. PubMed ID: 11735706
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of Von Zumbusch pustular psoriasis with infliximab.
    Trent JT; Kerdel FA
    J Cutan Med Surg; 2004; 8(4):224-8. PubMed ID: 16091999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid response to infliximab in severe pustular psoriasis, von Zumbusch type.
    Newland MR; Weinstein A; Kerdel F
    Int J Dermatol; 2002 Jul; 41(7):449-52. PubMed ID: 12121565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential use of infliximab and etanercept in generalized pustular psoriasis.
    Weisenseel P; Prinz JC
    Cutis; 2006 Sep; 78(3):197-9. PubMed ID: 17036664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases.
    Meiss F; Helmbold P; Meykadeh N; Gaber G; Marsch WCh; Fischer M
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):717-9. PubMed ID: 17448012
    [No Abstract]   [Full Text] [Related]  

  • 7. A dramatic response to a single dose of infliximab as rescue therapy in acute generalized pustular psoriasis of von Zumbusch associated with a neutrophilic cholangitis.
    Chandran NS; Chong WS
    Australas J Dermatol; 2010 Feb; 51(1):29-31. PubMed ID: 20148838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized pustular psoriasis complicated with idiopathic retroperitoneal fibrosis successfully treated with infliximab.
    Ito M; Akutsu K; Isobe M; Okazaki S; Ichiyama S; Hoashi T; Kanda N; Saeki H
    J Dermatol; 2021 Sep; 48(9):e436-e437. PubMed ID: 34080221
    [No Abstract]   [Full Text] [Related]  

  • 10. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitez L
    Acta Derm Venereol; 2008; 88(2):169-70. PubMed ID: 18311451
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of eosinophilic pustular folliculitis with response to infliximab.
    Hasegawa A; Kobayashi N; Fukumoto T; Asada H
    J Am Acad Dermatol; 2012 Oct; 67(4):e136-7. PubMed ID: 22980264
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of treatments for generalized pustular psoriasis.
    Kearns DG; Chat VS; Zang PD; Han G; Wu JJ
    J Dermatolog Treat; 2021 Aug; 32(5):492-494. PubMed ID: 31697211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression.
    Benoit S; Toksoy A; Bröcker EB; Gillitzer R; Goebeler M
    Br J Dermatol; 2004 May; 150(5):1009-12. PubMed ID: 15149518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term management of generalized pustular psoriasis with infliximab: case series.
    Routhouska SB; Sheth PB; Korman NJ
    J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
    Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
    Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitéz L; Meurer M
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secukinumab-induced paradoxical pustular psoriasis.
    Dogra S; Bishnoi A; Narang T; Handa S
    Clin Exp Dermatol; 2019 Jan; 44(1):72-73. PubMed ID: 30129214
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab: efficacy in psoriasis.
    Arsiwala S
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S25-34. PubMed ID: 23974692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids.
    Bonifati C; Trento E; Cordiali Fei P; Muscardin L; Amantea A; Carducci M
    Clin Exp Dermatol; 2005 Nov; 30(6):662-5. PubMed ID: 16197383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab for the treatment of severe pustular psoriasis.
    Elewski BE
    J Am Acad Dermatol; 2002 Nov; 47(5):796-7. PubMed ID: 12399781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.